4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide

CAS: 1441000-45-8

Ref. 3D-RHC00045

Produktinformation

• Name: 4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide

Beschreibung

4-Butoxy-N-[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamide (BDMOB) is a molecule that has been shown to act as a serotonin receptor agonist. It has been shown to have antidepressant effects in animal models of depression and is currently in clinical development for the treatment of depression. BDMOB also has anti-nociceptive activity, which may be due to its ability to inhibit the release of proinflammatory cytokines from macrophages and microglial cells. This drug also inhibits cancer cell growth and chronic pain.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 394.5 g/mol
• Formel: C₂₁H₃₄N₂O₅
• Reinheit: Min. 95%